Loading…
Employees: 1,237
Size Milbon (4919.T) is a Japan Consumer Staples company (Household/Personal Care) with a market value of $669M, the 925th largest of 1,379 Japan companies the cockpit tracks. Shares closed at ¥3,325 on 6 Nov 2026.
Performance Over six months the shares gained 30.1%, against -17.0% for the median peer and +1.8% for the Japan market (cap-weighted) — 4th highest of 21 in its peer set.
Growth Revenue grew 6.5% over the last twelve months (peer median +10.2%); the operating margin is 12.9% (peer median 8.2%).
Valuation It trades at 22.9× forward earnings against a peer median of 18.8× (6th most expensive of 19).
Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -11 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 8.0 points above its cost of capital (5.0% WACC).
Next results Next results expected around 13 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥54.9B | ¥52.9B | ¥51.3B | ¥47.8B | ¥45.2B |
| Revenue growth | — | +3% | +7% | +6% | — |
| Gross profit | ¥34.8B | ¥33.2B | ¥32.6B | ¥29.5B | ¥29.5B |
| EBITDA | ¥9.45B | ¥7.75B | ¥9.11B | ¥7.80B | ¥9.63B |
| Net income | ¥5.44B | ¥3.44B | ¥5.02B | ¥4.00B | ¥5.58B |
| Free cash flow | n/a | ¥2.44B | ¥5.43B | ¥2.17B | ¥1.95B |
| Capital expenditure | n/a | ¥3.33B | ¥2.54B | ¥3.21B | ¥3.82B |
| Total debt | ¥0 | ¥0 | ¥0 | ¥0 | ¥0 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 4919.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +2.8% | -9.0% | 5th highest of 21 |
| 6-month return | +30.1% | -17.0% | 4th highest of 21 |
| Distance from 52-week high | -5.4% | -36.2% | highest of 21 |
| Revenue growth (TTM) | +6.5% | +10.2% | 10th lowest of 21 |
| Operating margin | 12.9% | 8.2% | 6th highest of 21 |
| Forward P/E | 22.9× | 18.8× | 6th most expensive of 19 |
| Growth the price implies (Req g, 7 yrs) | -3.1% | 4.1% | 4th least demanding of 16 |
| Growth delivered (Del g) | +8.2% | +7.7% | 8th highest of 16 |
| Hurdle (Req g minus delivered) | -11.3 pp | -3.8 pp | 5th least demanding of 16 |
| ROIC minus cost of capital | +8.0 pp | +4.9 pp | 9th highest of 21 |
| EV / EBITDA | 9.8× | 10.8× | 5th cheapest of 13 |
| Net debt / EBITDA | -1.3× | -0.7× | 7th least indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Milbon 4919.T | Japan | $669M | +30% | +6% | 13% | 22.9× | -3.1% | +8.2% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $750M | -19% | +10% | 6% | 17.7× | 4.7% | +7.7% |
| Jyothy Labs JYOTHYLAB.NS | India | $773M | -23% | +5% | 8% | 30.9× | 35.0% | +8.9% |
| PZ Cussons PZC.L | United Kingdom | $566M | +30% | +5% | 11% | 13.3× | -1.7% | -2.1% |
| Cosmecca Korea 241710.KS | South Korea | $798M | +25% | +44% | 13% | 14.4× | -5.9% | +13.6% |
| Bajaj Consumer Care BAJAJCON.NS | India | $551M | -24% | +29% | 22% | 19.6× | 14.6% | +5.0% |
| Galaxy Surfactants GALAXYSURF.NS | India | $819M | +13% | +30% | 9% | 18.6× | 18.0% | +13.7% |
| Runben Biotechnology 603193.SS | China | $940M | -33% | +13% | 21% | 18.9× | 1.7% | +28.4% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $944M | +15% | +10% | 11% | 28.9× | 4.3% | +10.8% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $961M | +47% | +54% | 7% | 54.0× | n/a | n/a |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $464M | -25% | -7% | 4% | n/a | n/a | n/a |
| Noevir 4928.T | Japan | $977M | +3% | +1% | 16% | 19.4× | -4.8% | +4.5% |
| Tianjin Yiyi Hygiene Products 001206.SZ | China | $448M | -15% | -8% | 9% | 20.8× | 2.5% | +6.3% |
| SYoung 300740.SZ | China | $1.00B | -37% | +14% | 3% | 39.6× | 18.1% | +6.1% |
| Lafang China 603630.SS | China | $445M | -20% | -3% | 2% | 40.4× | n/a | n/a |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.06B | 0% | +74% | 18% | 12.1× | 11.5% | +49.0% |
| Jinglv Environment Science & Technology 001230.SZ | China | $415M | -22% | +28% | 11% | 14.7× | n/a | n/a |
| Liuzhou Liangmianzhen 600249.SS | China | $398M | -19% | -11% | -7% | n/a | n/a | n/a |
| McBride MCB.L | United Kingdom | $386M | +11% | +1% | 6% | 8.3× | -0.9% | +6.5% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.22B | -52% | +23% | 8% | 15.0× | -5.9% | +21.2% |
| Edgewell Personal Care EPC | United States | $1.29B | +32% | -7% | 6% | 12.4× | 4.1% | +2.7% |